Different smooth muscle cell (SMC) functions may require different cell phenotypes. Because the main pulmonary artery performs diverse functions, we hypothesized that it would contain heterogeneous SMC populations. If the hypothesis were confirmed, we wished to determine the developmental origin of the different populations. Using specific antibodies, we analyzed the expression of smooth muscle (SM) contractile and cytoskeletal proteins (a-SM-actin, SM myosin, calponin, desmin, and meta-vinculin) in the main pulmonary artery of fetal (60 to 270 days of gestation), neonatal, and adult animals. We demonstrated the existence of a complex, sitespecific heterogeneity in the structure and cellular composition of the pulmonary arterial wall. We found that at least four cell/SMC phenotypes, based on immunobiochemical characteristics, cell morphology, and elastic lamellae arrangement pattern, were simultaneously expressed within the mature arterial media. Further, we were able to assess phenotypic alterations in each of the four identified cell populations during development. We found that each cell population within the arterial media expressed a-SM-actin at least at certain stages of development, thus demonstrating its smooth muscle identity. However, each cell population progressed along different developmental pathways, suggesting the existence of multiple and distinct cell lineages. A novel anti-metavinculin antibody described in this study reliably distinguished one SMC population from the others during all the developmental stages analyzed. We conclude that the pulmonary arterial media is indeed composed of multiple phenotypically distinct cell/SMC populations with unique lineages. We speculate that these distinct cell populations may serve different functions within the arterial media and may also respond in unique ways to pathophysiological stimuli. (Circ Res. 1994; 75:669-681.) Key Words * vascular smooth muscle cells * cell heterogeneity * vascular development * pulmonary hypertension * contractile and cytoskeletal protein expression T he pulmonary arterial media has previously been thought to be composed of a phenotypically homogeneous population of smooth muscle cells (SMCs). However, the possibility that the arterial media is composed of phenotypically heterogeneous SMC populations is raised by the fact that SMCs within the media must perform various functions to maintain homeostasis of the vessel wall. For example, the main pulmonary artery (MPA) has been shown to stretch both longitudinally and circumferentially by 5% to 15% with each systole, a function requiring variable orientation of SMC fibers within the wall.' In response to sympathetic neural stimulation, conduit arteries have been shown to stiffen, demonstrating a significant contractile capability of the SMCs within these vessels.2 The MPA has also been shown to vary in thickness around its circumference, suggesting nonuniformity in wall properties.3 In addition, in response to chronic pressure elevation, conduit pulmonary artery SMCs proliferate and increase their production of extracellular matrix proteins.4,5 Whether these varying functions and responses can be accomplished by SMCs of a single phenotype or whether several different phenotypes of SMCs are required is not known.
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Key Words * vascular smooth muscle cells * cell heterogeneity * vascular development * pulmonary hypertension * contractile and cytoskeletal protein expression T he pulmonary arterial media has previously been thought to be composed of a phenotypically homogeneous population of smooth muscle cells (SMCs). However, the possibility that the arterial media is composed of phenotypically heterogeneous SMC populations is raised by the fact that SMCs within the media must perform various functions to maintain homeostasis of the vessel wall. For example, the main pulmonary artery (MPA) has been shown to stretch both longitudinally and circumferentially by 5% to 15% with each systole, a function requiring variable orientation of SMC fibers within the wall.' In response to sympathetic neural stimulation, conduit arteries have been shown to stiffen, demonstrating a significant contractile capability of the SMCs within these vessels. 2 The MPA has also been shown to vary in thickness around its circumference, suggesting nonuniformity in wall properties.3 In addition, in response to chronic pressure elevation, conduit pulmonary artery SMCs proliferate and increase their production of extracellular matrix proteins.4,5 Whether these varying functions and responses can be accomplished by SMCs of a single phenotype or whether several different phenotypes of SMCs are required is not known.
Experimental evidence supporting the concept of SMC phenotypic heterogeneity within the mammalian vascular wall has come from studies in the systemic circulation.6-8 However, most of the in vivo experimental data have been obtained by comparison of SMC phenotypes either from different locations of the vascular tree9-1" or from distinct vessel wall layers (ie, intima versus media) of normal or atherosclerotic human or injured animal arteries.12-'8 Less information exists as to whether SMC heterogeneity is maintained in the arterial media in vivo at a specific location.10'9-23 In our previous studies, using routine staining methods, we observed SMCs in the outer media of the MPA of the newborn calves, which varied in arrangement and orientation. In addition, we found differences in tropoelastin-producing capabilities of SMCs composing conduit pulmonary arteries of neonatal calves with severe pulmonary hypertension as well as regional differences in cell proliferation.4'24'25 Therefore, on the basis of reports of SMC heterogeneity from the systemic circulation, our own previous findings, and the varied functions required of the MPA, we hypothesized that the normal MPA media, both adult and neonatal, would be composed of phenotypically heterogeneous SMC populations. If this hypothesis were confirmed, we wished to determine the developmental origin of the different populations. Our approach to test this hypothesis was to examine the expression of a number of contractile and cytoskeletal proteins by SMCs composing the media of the adult and developing bovine MPA and its systemic counterpart, the aortic arch. Several biochemical and immunocytochemical studies have demonstrated that certain variants of cytocontractile and cytoskeletal proteins are restricted to muscle tissue, are developmentally regulated, and thus can serve as reliable markers of the phenotypic transitions that SMCs undergo during development and in certain disease states.15,26 Therefore, we chose to analyze the expression of smooth musclespecific variants of actin, myosin heavy chains (MHCs), calponin, desmin, vinculin, and caldesmon as the markers of SMC differentiation in this study.
Our results demonstrated that at least four phenotypically distinct cell/SMC populations based on immunobiochemical characteristics, cell morphology, and elastic lamellae arrangement pattern can be identified within the normal adult bovine arterial media in vivo. Further, we showed that each of the cell/SMC populations identified within the mature media demonstrated its smooth muscle identity at least at certain stages of fetal development. However, each cell population progressed along different developmental pathways, suggesting the existence of multiple and distinct cell lineages. These findings are important with regard to the question of whether phenotypically different cells/SMCs within the arterial media contribute in unique ways to maintaining homeostasis in the pulmonary circulation under normal and pathological conditions.
Materials and Methods Tissue Samples
Specimens of bovine MPA were isolated from adult (2-yearold) animals (n=5), neonatal (1to 15-day-old) calves (n-6), and fetuses (60, 70, 80, 90, 100, 110, 120, 130, 140, 160, 180, 240 , and 270 days of gestation) (n=2 to 4 of each). The gestational ages of fetal calves were calculated according to the method of Evans and Sack.27 In addition, specimens of aortic arch were obtained from each animal at the same level and distance from the heart as for MPA. For immunofluorescent analysis and routine histochemistry, rings of freshly isolated arteries were embedded in OCT compound (Miles Inc), frozen slowly in cold hexane to prevent tissue fracturing, and stored at -70°C until use. Frozen sections were cut at 5 grm, fixed in absolute acetone for 5 minutes at room temperature, and processed for staining as described below. For immunostaining with anti-calponin antibodies, 4% formalin was used to fix tissue sections. For immunoblotting analysis, samples of arterial media were prepared as described below.
Antibodies
The following antibodies against smooth muscle variants of contractile and cytoskeletal proteins were used in this study.
Monoclonal anti-a-smooth muscle actin (a-SM-actin) and rabbit anti-actin antibodies were purchased from Sigma, and polyclonal rabbit anti-desmin antibodies from DAKO Corp. Two monoclonal antibodies (Mabs), here called SM-M5 and SM-M10, against smooth muscle myosin heavy chain (SM-MHC) isoforms were generated according to Kohler and Milstein's protocol,28 with minor modifications, using a crude extract of cytoskeletal proteins from human myometrium. 29 Since human smooth muscle tissue was used as the immuno- Immunoprecipitation with the tested antibodies (SM-M5 or M-VN) followed by immunoblotting with the previously described antibodies (smMS or VIIF9): a, immunoprecipitate was obtained with SM-M5 Mab, and subsequent immunoblotting analysis was performed with polyclonal smMS antibodies and revealed two polypeptides of apparent molecular masses of 204 and 200 kD; b, immunoprecipitate was obtained with polyclonal M-VN antibodies, and subsequent immunoblotting analysis was performed with Mab VIIF9 and revealed two polypeptides of apparent molecular masses of 150 kD (meta-vincuiin) and 130 kD (vinculin); c, control: immunoprecipitate was obtained with SM-M5 Mab, and subsequent immunoblotting was performed with M-VN antibodies. B, lmmunoprecipitation with the previously described antibodies (smMS or VIIF9) followed by immunoblotting with the tested antibodies (SM-M5 or M-VN): a, immunoprecipitate was obtained with polyclonal smMS antibodies, and subsequent immunoblotting analysis was performed with Mab SM-M5 and revealed two polypeptides of apparent molecular masses of 204 and 200 kD; b, immunoprecipitate was obtained with Mab VIIF9, and subsequent immunoblotting analysis was performed with polyclonal M-VN antibodies and revealed only one polypeptide of apparent molecular mass of 150 kD (meta-vinculin); c, control: immunoprecipitate was obtained with M-VN antibodies, and subsequent immunoblotting was performed with Mab SM-M5.
gen, cross-reactivity with bovine smooth muscle was confirmed by Western blotting, immunoprecipitation, and immunofluorescent staining of homologous/heterologous tissues (see "Results"). The IgG fraction of affinity-purified rabbit antibodies v (here called smMS) against bovine aortic smooth muscle myosin, reacting with both SM-1 and SM-2 SM-MHC isoforms, and rabbit antiserum raised against human platelet nonmuscle myosin (here called aPM) were kindly provided by Dr R.S. Adelstein (National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md).30 Affinity-purified polyclonal anti-meta-vinculin antibodies (here called M-VN) were raised in rabbits against a fusion protein containing glutathione-S-transferase and a fragment of the vinculin protein (908 to 916 amino acid residues) with a meta-vinculin insertion. 31 Briefly, rabbits were immunized with 1 mg SC of fusion protein. Then the animals received two boosts with 0.5 mg of fusion protein at 3-week intervals. Serum was collected 10 days after the last boost. Serum was adsorbed on metavinculin and immobilized on a nitrocellulose filter, and adsorbed antibodies were eluted with pH 2.7 buffer, neutralized, and diluted in phosphate-buffered saline (PBS) containing 1 ] L 1 I L2 , 1 mg/mL bovine serum albumin. Antibody specificity for M-VN was confirmed by Western blotting, immunoprecipitation, and immunofluorescent staining of homologous/heterologous tissues (see "Results"). Mouse Mab revealing vinculin variants and equally reacting with vinculin and meta-vinculin (clone VIIF9) and Mab against calponin (called mnCALP) have been characterized previously.'6'26 For Western blot analysis of caldesmon variant expression, the polyclonal affinity-purified antibodies (here called CALD) raised against chicken gizzard caldesmon were generously provided by Dr V.P. Shirinsky (Institute of Experimental Cardiology, Cardiology Research Center, Moscow, Russia). The antibody recognized both 150and 77-kD caldesmon variants, although the affinity for highmolecular-weight (150-kD) caldesmon was somewhat greater. 26 
Immunofluorescent Analysis
Fixed sections were incubated with primary antibodies for 1 hour at room temperature. Monoclonal antibodies SM-M5, SM-M0I mnCALP, and VIIF9 were used as undiluted hybridoma supernatants. Antibodies against SM myosin, a-SM-actin, total actin, desmin, and meta-vinculin were diluted in blocking solution (5% calf serum in PBS) at 1:1000, 1:100, 1:50, 1:20, and 1:10, respectively. Sections were processed for immunofluorescence by use of a biotin-streptavidin system (biotinylated antimouse and anti-rabbit IgG were purchased from Calbiochem; Streptavidin-Texas Red conjugate, from Amersham). All reagents used in the immunofluorescent staining procedure were applied at the dilutions recommended by the supplier. For immunofluorescent double-labeling staining experiments, Mab staining was done first, and then the section was stained with polyclonal antibodies. Stained sections were examined with an inverted fluorescent microscope (Nikon, Optiphot). Micrographs were taken on Kodak T-MAX 400 film.
Histochemical Staining
The Verhoeff-van Gieson method was used to identify elastic fibers within the vessel wall and was performed as previously described.32
Tissue Preparation for SDS-Polyacrylamide Gel Electrophoresis
For immunobiochemical analysis, freshly isolated arteries were obtained, and the endothelium and adventitia were carefully removed. To ensure complete removal of the adventitia, a thin portion of the outer medial layer was also discarded. The remaining media was easily separated, according to the specific pattern of elastic lamellar distribution and thus distinct mechanical properties, into three layers: a very thin preluminal layer, an inner-middle layer, and a thick outer layer (LI, L2, and L3, respectively, in Fig 3) . The quality of separation was checked by immunostaining with smooth muscle-specific antibodies. Tissue samples were frozen and minced in liquid nitrogen. Protein extraction and SDS-gel electrophoresis (using 7.5% gels) were performed according to Laemmli.33 To obtain better resolution of MHC isoforms, crude myosin pyrophosphate extracts were electrophoresed in 5% SDS gels as previously described.23
Western Blotting and Immunoprecipitation
Western blot analysis of MHC, vinculin, and caldesmon isoforms in protein extracts from different layers of adult arterial media using specific antibodies was carried out according to the method of Towbin et al. 34 Peroxidase-conjugated goat anti-rabbit or anti-mouse IgG (Bio-Rad) was used as secondary antibody.
Immunoprecipitation assays with SM-M5, SM-M10, and M-VN antibodies were performed as previously described.'6
Results

Specificity of Antibodies
Specificity of the monoclonal anti-smooth muscle MHC antibodies (clones SM-M5 and SM-M10 [because the results obtained with both antibodies were identical, we refer in this article to monoclonal antibody SM-M5 only]) and the polyclonal anti-meta-vinculin antibody (M-VN) used in this study was demonstrated by Western blotting, immunoprecipitation assay, and immunofluorescent staining of homologous and heterologous tissues.
In Western blotting assays of crude myosin preparations from adult bovine aortic media electrophoresed in 5% SDS gels, the monoclonal antibody (Mab) SM-M5 recognized two polypeptides with electrophoretic mobility of 204 and 200 kD, a pattern similar to that obtained with the previously described polyclonal smMS antibody ( Immunoprecipitation was carried out to identify the polypeptides recognized by SM-M5 and M-VN antibodies (Fig 2) . Immunoprecipitates from extract of normal adult aortic media were obtained with SM-M5 and M-VN antibodies and analyzed by an immunoblotting assay with previously described antibodies: polyclonal smMS (recognizing both SM-1 and SM-2 SM-MHC30) and monoclonal VIIF9 (recognizing both vinculin and meta-vinculin polypeptides26). The results are shown in Fig 2A. A reverse procedure was also carried out using indicates SMCs arranged in compact cell clusters oriented longitudinally; "i," cells in the "interstitial" areas between the compact cell clusters. Note the intense staining of compact cell clusters ("C") with all antibodies and the absence of staining with smooth muscle-specific antibodies of "interstitial" ("i") cells (b through f). The presence of cells-in "interstitial" areas is confirmed by the staining with antibodies to total actin (a). Bar=80 gm. smMS and VIIF9 antibodies to obtain immunoprecipitates and SM-M5 and M-VN antibodies for subsequent Western blotting analysis ( Fig 2B) . Using this approach, we demonstrated that Mab SM-M5 recognized the two SM-MHCs (SM-1 [204 kD] and SM-2 [200 kD]) and that polyclonal M-VN antibodies recognized meta-vinculin (150 kD). As a control, smMS immunoprecipitate was analyzed by Western assay with M-VN antibodies, and VIIF9 immunoprecipitate with SM-M5 Mab. In this set of experiments, no reaction was identified (Fig 2A  and 2B , lanes c).
Last, specificity of the antibodies was determined by indirect immunofluorescent staining of homologous and heterologous bovine and human tissues. All the antibodies specifically stained muscle tissue and showed no reactivity with nonmuscle tissues or cells ( (Fig 3A and 3B ). From these results, the media could be subdivided into three distinct layers: (1) a very thin preluminal layer (designated L1) just under the internal elastic lamellae, (2) an inner-middle layer nearly one third of the arterial wall thickness (designated L2), and (3) a thick outer layer almost two thirds of the total arterial media thickness (designated L3). Within the preluminal media (L1), small irregularshaped cells were observed between punctate elastic fragments. In the inner-middle media (L2), elongated cells were oriented circumferentially between numerous and well-developed elastic lamellae. In the outer media (L3), two distinct patterns of cell and elastic fiber arrangement were observed: (1) areas devoid of elastic lamellae where cells were closely adjacent to each other and formed compact clusters ("C") that were oriented longitudinally and (2) elastic-rich interstitial areas ("i") observed between the cell clusters where elongated and thin cells were oriented circumferentially (Fig 3) .
SMC Phenotype
To characterize the phenotype of cells within the different medial layers described above, indirect immunofluorescent staining of adult MPA and aortic arch was performed using specific antibodies against musclespecific variants of contractile and cytoskeletal proteins (a-SM-actin, SM myosin, calponin, desmin, and metavinculin). At least three distinct cell/SMC phenotypes with regard to contractile and cytoskeletal protein ex- pression were identified within the mature arterial media (Figs 4 and 5 ). (However, more than three cell/SMC phenotypes could be described with regard to desmin expression. A mosaic pattern of desmin expression was revealed by double immunofluorescent staining using a-SM-actin/desmin, SM myosin/desmin, or calponin/desmin pairs of monoclonal/polyclonal antibodies [data not shown].) Cells within the preluminal media (L1) were negative for all the smooth muscle markers analyzed (Fig 4, LI) . In the inner-middle media (L2), SMCs stained positively for a-SM-actin, SM myosin, calponin, and desmin but were negative for M-VN ( In the outer media (L3) of the MPA and aortic arch, two distinct cell phenotypes were observed ( Fig 5) . SMCs in compact cell clusters ("C") stained brightly with all smooth muscle antibodies, including M-VN, whereas cells in the interstitial areas ("i") were either negative for all the smooth muscle antibodies examined (thus phenotypically resembling Li cells) or (in some specimens) were very weakly stained with anti-a-SM-actin, SM myosin, or calponin antibodies yet were always negative with M-VN antibodies.
To exclude the possibility of antigen masking, we performed immunofluorescent staining on the tissue sections either fixed with different reagents (acetone, 4% buffered formaldehyde, methanol) or pretreated with ionic or nonionic detergents (0.1% SDS and 0.1% Triton X-100, respectively). Neither of these procedures affected the immunostaining pattern described above.
Western Blot Assays Among all the smooth muscle markers analyzed in this study by the immunofluorescent staining procedure, only meta-vinculin expression was found to be restricted to a specific SMC population in the outer media. It has recently been established that vinculin polymorphism arises through a tissue-specific alternative splicing of corresponding primary mRNA transcript. We therefore investigated whether other cytodifferentiation-related proteins, whose expression is also known to be regulated at the level of alternative mRNA splicing, would be coordinately expressed with meta-vinculin. For this purpose, we chose to analyze the composition of alternatively spliced variants of caldesmon and SM-MHC in different layers of the mature arterial media by Western blot analysis. In addition, because the expression of meta-vinculin was found to be specifically restricted to SMCs in the outer media, Western blot analysis was also performed with M-VN antibodies to ensure the absence of antigen masking in the immunostaining procedure and as a control to evaluate the accuracy of layer separation. The data obtained are presented in Fig 6. Protein extract from the outer media (L3) contained a relatively high amount of meta-vinculin (150 kD), while the extracts from the preluminal (L1) and inner-middle (L2) media did not contain any meta-vinculin, thus demonstrating that these samples were not contaminated with meta-vinculin-positive SMCs. Protein extract from the preluminal media (L1) contained only nonmuscle variants of vinculin (130 kD), caldesmon (77 kD), and MHC (198 kD). SMCs in the inner-middle media (L2) did not express meta-vinculin, smooth muscle (150-kD) caldesmon, and 200-kD SM-MHC (SM-2); however, the 204-kD SM-MHC isoform (SM-1) was present in SMCs of this medial layer, as were relatively high levels of nonmuscle proteins (77-kD caldesmon, vinculin, and 198-kD nonmusele MHC). Protein extract from the outer media (L3) (shown by immunostaining to be composed of two distinct SMC populations) contained high amounts of meta-vinculin, 150-kD caldesmon, and both SM-1 and SM-2 MHC isoforms, in addition to relatively low amounts of 77-kD nonmuscle caldesmon and 198-kD nonmuscle MHC.
Neonatal Arteries
In neonatal (1to 15-day-old) calves, the arterial media was found to be structurally similar to that of the adult. Again, in the outer media, both compact cell clusters ("C") and interstitial areas ("i") could be distinguished (Fig 7) . With regard to smooth muscle protein expression, cells in the preluminal (L1) (not shown) and inner-middle (L2) media were phenotypically similar to those in the same layers of the mature vessel wall. However, in the outer media (L3) of neonatal arteries, two differences compared with the adult arteries were observed: (1) in the neonatal vessel wall fragmented) elastic fibers (Fig 7a) , whereas SMC clusters in the mature media were devoid of elastic fibers ( Fig 3B) , and (2) SMCs in "interstitial" ("i") areas in the neonatal wall were positive for a-SM-actin, SM myosin, calponin, and desmin but not meta-vinculin (Fig  7c through 7g) , whereas SMCs in the corresponding regions ("i") in the mature media were negative for all the smooth muscle markers analyzed ( Fig 5) .
Fetal Development
Because of the dramatic differences found in the phenotype of SMCs composing both the neonatal and mature vessel walls, we wanted to investigate the molecular changes that phenotypically distinct SMCs might undergo during fetal development in an effort to examine the possibility that SMCs of distinct lineages exist and progress along different differentiation/developmental pathways. The observation that phenotypically distinct cell/ SMCs were localized within different layers of the arte-rial media or exhibited a specific pattern of cell arrangement enabled us to follow the developmental alterations of each cell/SMC population identified in the adult. For this purpose, we performed immunofluorescent analysis of cytodifferentiation-related protein expression and routine elastic staining on fetal MPA and aortic arch tissue samples during the gestational period of 60 to 270 days (term in the bovine species is 285 days).
Immunofluorescent staining of total actin (revealing all the cells), as well as routine elastic staining, demonstrated that the arterial media of early (60to 100-day) fetuses was structurally homogeneous (Fig 8a and 8b) . The preluminal media (L1) demonstrated some reactivity with a-SM-actin antibodies (Fig 8c) but was negative for all other smooth muscle markers (Fig 8d through 8f and 8h) . However, at all subsequent gestational stages analyzed, cells in the preluminal media did not express a-SM-actin. Immunofluorescent analysis of smooth muscle protein expression in the remaining media of the 60to 80-day fetal MPA demonstrated immunoreactivity of medial SMCs with a-SM-actin, SM myosin, and calponin (Fig 8c through 8e) . Desmin-positive cells were identified only in the outermost media (Fig 8f) . At this gestational stage, no cells in the arterial media expressed metavinculin (Fig 8h) , whereas all cells expressed vinculin (Fig  8g) . By 90 to 110 days of gestation, desmin-positive SMCs were observed in both the outer (L3) and inner-middle (L2) media. At this time, occasional small groups of meta-vinculin-positive SMCs were identified in the outermost media (data not shown).
As gestation progressed (120 to 140 days), the pattern of meta-vinculin immunoreactivity became more prominent: meta-vinculin-positive groups of SMCs in the outer media appeared as bright patches or foci within meta-vinculinnegative areas (Fig 9h) . All SMCs, except those in the preluminal (L1) media (not shown), were now brightly stained with antibodies against a-SM-actin, SM myosin, calponin, and desmin (Fig 9c through 9f) . At approximately 130 to 140 days of gestation, the first evidence for structural heterogeneity in the outer media was observed: meta-vinculin-positive cells now appeared as compact cell clusters with a longitudinal orientation, whereas cells in the meta-vinculin-negative areas were characterized by a circumferential orientation and more sparse density (not shown). In the 180-day fetal MPA, two distinct patterns of cell arrangement were identified: compact cell clusters ("C") with sheet-like groups of closely adjacent cells oriented longitudinally between the elastic lamellae and "interstitial" areas ('i') where circumferentially oriented, more sparse cells were observed between the elastic fibers ( Fig 10) . Immunofluorescent analysis showed that a-SMactin, SM myosin, calponin, and desmin were expressed in all SMCs of the middle (L2) (not shown) and outer (L3) media (Fig lOc through 10f) , whereas meta-vinculin expression was specifically restricted to SMCs in the compact cell clusters ("C") in the outer media (Fig lOh) . Notably, in the arteries of 180-day fetuses, meta-vinculinpositive foci of SMCs were penetrated with elastic lamellae; however, they appeared to be thinner than in the other areas of the arterial media (Fig 10a) . The MPA of late gestational fetuses (240 to 270 days) demonstrated structural and immunostaining patterns identical to those observed in the vessel wall of neonatal (1to 15-day-old) calves.
Both the routine elastic staining and immunostaining with various smooth muscle antibodies revealed that the aortic arch had a structure and pattern of reactivity with all antibodies tested strikingly similar to that of the MPA at all stages of development. Both immunostaining and elastic staining of longitudinally cut sections at all developmental ages confirmed the existence of the structural patterns described above.
Discussion
The present study demonstrates the existence of a complex, site-specific heterogeneity in the structure and cellular composition of the bovine MPA media. Additionally, phenotypic heterogeneity of SMCs composing the media was demonstrated by the marked differences in the expression of several contractile and cytoskeletal proteins. These findings both complement and extend the observations of previous studies showing that the mature arterial media is indeed a highly complex and heterogeneous structure. Different laboratories have previously reported the existence of heterogeneity in SMC phenotype within the aortic media of various mammalian species with regard to expression of desmin,10,22 ca-SM-actin,'935 and MHC isotypes.20R21,23
Previously, however, phenotypic diversity of SMCs composing the arterial media had not been systematically studied through simultaneous analysis of a number of different smooth muscle markers in the mature and developing vessels. Therefore, it had remained unclear whether there were diverse and stable subpopulations of SMCs within the mature arterial media at a specific location or whether the observed differences in contractile and cytoskeletal protein expression were simply due to transient phenotypic modulation of a single differentiated arterial SMC.
From the difTerential expression of smooth musclespecific proteins, cell morphology, and pattern of elastic a' §'T: _ A, Z.it -rt 5::-4'lamellae arrangement, we were able to demonstrate that at least four cell/SMC phenotypes were simultaneously expressed within the mature bovine arterial media. Immunobiochemical studies alone would have suggested that only three cell/SMC populations could be distinguished within the mature media. However, when cell morphology, orientation, and the pattern of elastic lamellae arrangement were also considered, the existence of four distinct cell/SMC populations became obvious, since each of the four distinct cell/SMC populations described exhibited unique characteristics ( Table 2 and Fig 11) . The presence of "poorly differentiated" cells or cells lacking specific smooth muscle characteristics in the preluminal (L1) media in the bovine species is consistent with electron microscopic studies in the developing porcine and human pulmonary vessel wall, in which less differentiated cells have been identified within the inner compared with the outer media of both the neonate and the adult. [36] [37] [38] These observations raise the possibility that an immature cell population, situated close to the lumen, could exhibit unique responses to vascular injury, such as greater proliferative and synthetic potentials, compared with SMCs situated in the media farther from the lumen. Interestingly, the phenotype of cells in "interstitial" areas of the outer media (L3-"i"-cells) in adults could be also described as "nonmuscle-like," similar to that of cells in the preluminal media (L1-cells) . However, in late fetal and neonatal life, L3-"i"-cells expressed not only a-SM-actin (as did Li-cells in the early fetal period) but also SM myosin, calponin, and desmin. This suggests that L3-"i"cells have a smooth muscle origin. The existence of such an abundant "nonmuscle-like" cell or immature SMC population within the mature arterial media has not been previously described in vivo.
A population of SMCs identified in the inner-middle media (L2) of both the neonatal and mature vessel wall expressed a phenotype that could be described as "intermediate" in nature, since they expressed a-SMactin, SM-1 MHC, calponin, and desmin but not metavinculin, 150-kD caldesmon, or SM-2 MHC. Another population of SMCs observed in compact clusters in the outer (L3) media ("C" in Figs 5 and 11) could be characterized as highly differentiated, on the basis of the expression of all the smooth muscle markers analyzed (Table 2) . Notably, this SMC population exhibited a pattern of cell arrangement unique for vascular SMCs (ie, the SMCs were closely adjacent to each other and formed compact cell clusters oriented longitudinally). This pattern of cell arrangement is characteristic of nonvascular SMCs (in trachea, esophagus, stomach, gut, and uterus) but has not been described for arterial smooth muscle. 16 Interestingly, elastic lamellae were conspicuously absent in the SMC clusters, and the
Adventitia FIG 11 . Schematic diagram demonstrating the structural and cellular heterogeneity within the mature bovine main pulmonary arterial media. Li indicates preluminal media; L2, inner-middle media; and L3, outer media. "C" indicates smooth muscle cells in the outer media arranged in compact cell clusters oriented longitudinally; "i," cells in the "interstitial" areas between the compact cell clusters. elastic fibers abruptly ended where the cell cluster began (Fig 3) . The existence of such a wide variety of SMC phenotypes within the media, with profoundly different patterns of contractile and cytoskeletal protein expression, suggests the possibility of markedly different functional properties of these SMCs within the vessel wall. At the present time, however, there is no direct evidence demonstrating specific functions of smooth muscle isoforms of contractile and cytoskeletal proteins. The observation of SMC heterogeneity in the mature vessel wall in this and previous studies raised the question as to how this phenotypic diversity was achieved. That is, are there specific subpopulations of less differentiated SMCs that persist throughout all stages of development, or is the observed SMC heterogeneity the result of a temporal and reversible "modulation" of a single "differentiated" SMC phenotype? The data from previous studies could not address this question because the arterial media in mammalian species such as the rat, rabbit, and human appears to be structurally rather homogeneous, thus precluding analysis of phenotypic alterations in the same SMC population at different developmental stages. In the large bovine arteries, however, we were able to follow the developmental pathways of distinct SMC populations because we found that each of the four identified SMC populations either was localized to a specific layer of the arterial media or exhibited a specific pattern of cell arrangement or of cytoskeletal protein expression (eg, meta-vinculin). These observations enabled us to analyze phenotypic alterations of each of the four cell/SMC populations at different developmental stages. Our data support the concept raised by previous investigators regarding the existence of multiple and stable subpopulations of SMCs with distinct lineages within the arterial media in vivo.6,7 We found in early fetal development (60 to 100 days of gestation) that the structure of the main pulmonary vessel wall was rather homogeneous and that all SMCs in the arterial media expressed at least a-SM-actin. Later in development, however, different medial SMCs were shown to progress along distinct differentiation pathways such that by adulthood, a marked heterogeneity of SMC phenotypes was observed in the arterial media. A schematic interpretation of the results of immunostaining analysis showing the developmental differentiation pathways of the four distinct arterial cell/SMC populations is presented in Fig 12. Cells in the preluminal media (L1) demonstrated a transient expression of a-SM-actin in early fetal development and thereafter did not express any of the smooth muscle markers analyzed. In the other three SMC populations in the arterial media, however, differentiation appeared to occur in three phases. During the first phase (60 to 100 days of gestation), SMCs progressively accumulated smooth muscle proteins, a-SM-actin, and SM myosin, followed by calponin and then desmin. During the second phase (100 days of gestation to a few weeks after birth), a specific subpopulation of SMCs in the outer media (later called L3-"C"-SMCs) began to express meta-vinculin, whereas the other SMCs did not express meta-vinculin at any developmental stage. In this period, the phenotypes of SMCs in the inner-middle media (L2-SMCs) and in the "interstitial" areas of the outer media (L3-"i"-cells) were indistinguishable. However, by adulthood (phase three), L2-SMCs continued to express the same phenotype, whereas L3-"i"-SMCs appeared to downregulate the expression of smooth muscle markers during postnatal development such that by maturity they appeared as "nonmuscle-like" cells. Although the concept of "phenotypic modulation"39 has implied that SMCs of the media, in response to injury of the vessel, lose certain characteristics of the differentiated or "contractile" phenotype, our results not only provide evidence for the existence of multiple unique subpopulations of SMCs but also suggest the existence of a developmentally regulated "phenotypic modulation" of a distinct SMC subpopulation within the arterial media during normal vessel wall maturation.
Of particular interest was the fact that meta-vinculin expression was restricted to a specific SMC population (L3-"C"-SMCs) throughout all stages of fetal and postnatal development and was never identified in other populations of SMCs of the MPA. Therefore, the novel antimeta-vinculin antibody described in this study could be used for identification of this particular SMC population and for distinguishing it from other arterial SMCs, which in late fetal and early postnatal periods express a number of smooth muscle proteins (a-SM-actin, SM myosin, calponin, and desmin). Additionally, since a specific cell population can now be identified and followed, this antibody will be useful in studies examining the responses of phenotypically distinct SMC populations to both developmental and pathophysiological stimuli.
In contrast to meta-vinculin expression, a-SM-actin was identified in all SMCs at least at certain developmental stages. It has recently been established that vinculin variants arise through alternative splicing of the primary mRNA transcript,31 whereas isoactins are known to be encoded by different genes.4041 Thus, the observed differences in the pattern of expression of meta-vinculin and a-SM-actin by arterial SMCs might reflect differences in the regulatory mechanisms of cytoskeletal protein expression in distinct SMC populations. In support of this idea, we found that two other proteins, whose expression is also known to be regulated at the level of alternative mRNA splicing (150-kD caldesmon and 200-kD SM-MHC [SM-2]), were coordinately expressed with meta-vinculin in SMCs of the outer media. Because the immunostaining analysis showed that the outer media (L3) was composed of the two phenotypically distinct SMC populations (one expressing all the smooth muscle markers and the other expressing none), we assumed ( Table 2 ) that the 150-kD caldesmon and SM-2 MHC, identified in protein extracts from the outer media (Fig 6) , were expressed by the population of highly differentiated SMCs ("C"-SMC in Figs 5 and 11) but not by "nonmusclelike" cells ("i" in Figs 5 and 11) . These findings suggest the existence of developmentally regulated differential expression of specific splicing factors by distinct SMC populations within the arterial media.
The observation of heterogeneous SMC populations existing within the arterial media raises important questions as to whether this phenotypic diversity contributes to the functional diversity needed by the MPA. Diverse functions are required of the vessel wall under both normal and pathological conditions. It is possible that in response to pathological stimuli some medial SMCs maintain "contractile" functions, whereas others exhibit proliferative and/or synthetic behavior. Diversity in responses would lend itself to better maintenance of vascular homeostasis.
